1. Living donor liver transplantation: Eastern experiences
K. Tanaka, Y. Ogura, T. Kiuchi, Y. Inomata, S. Uemoto, H. Furukawa 
HPB 
Volume 6, Issue 2, Pages (May 2004)
DOI: /
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

2. Figure 1
Annual statistics for total liver transplantations in each Eastern country.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

3. Figure 2
Annual statistics for LDLT, cadaveric liver transplantation and split liver transplantation in Eastern countries. Although the number of cadaveric liver transplantations increased gradually, note the disproportionately rapid annual increase of LDLT. *2001 analysis ended in April 2001.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

4. Figure 3
Proportion of cumulative total number of LDLT (white) and cadaveric liver transplantations (grey) between 1989 and 2001 in each Asian country. *China includes Hong Kong data.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

5. Figure 4
Annual distribution by recipient population in eastern LDLT. After the introduction of right lobe graft in Hong Kong (1996), Korea (1997), Japan (1998) and Taiwan (2000), the number of adult LDLTs and total LDLTs increased rapidly. *2001 analysis ended in April 2001.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

6. Figure 5
Indications for LDLT in Eastern countries. Data are expressed as percentage of 1511 LDLT cases.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

7. Figure 6
Geographic distribution of chronic HBV infection. Note the high prevalence of HBV infection in East Asia, excluding Japan.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions

8. Figure 7
Kaplan–Meier survival curve showing differences by recipient age in ABO blood type‐incompatible LDLT before the introduction of intraportal infusion (a). Due to this poor survival in adult incompatible LDLT, the intraportal infusion protocol was adopted by the Kyoto University team. Kaplan–Meier survival curve showing the differences between original protocol and modified protocol for incompatible LDLT in larger recipients (median: 53.8 years; range: 14–60 years) (b). PV, portal vein; HA, hepatic artery.
HPB 2004 6, 88-94DOI: ( / )
Copyright © 2004 International Hepato-Pancreato-Biliary Association Terms and Conditions